Newsfeeds Archive - Page 4 of 6

2 minute read

News

Phil, Inc. Forges Strategic Partnership With Syneos Health To Improve Patient Access To Prescriptions

October 25, 7:33 AM

Phil Inc., a patient access platform company that revolutionizes life science product commercialization with technology to improve patient prescription access, today announced an exclusive partnership with Syneos

SYNH

1 minute read

JP Morgan Downgrades Syneos Health to Neutral, Lowers Price Target to $53

By Benzinga Newsdesk

October 18, 4:45 AM

JP Morgan analyst Tycho Peterson downgrades Syneos Health (NASDAQ:SYNH) from Overweight to Neutral and lowers the price target from $85 to $53.

SYNH

47 minute read

Options

Stocks That Hit 52-Week Lows On Tuesday

By Benzinga Insights

October 11, 12:47 PM

On Tuesday, 838 companies hit new 52-week lows.

$APE

1 minute read

Analyst Ratings

Expert Ratings for Syneos Health

By Benzinga Insights

October 5, 9:27 AM

Analysts have provided the following ratings for Syneos Health (NASDAQ:SYNH) within the last quarter:

SYNH

1 minute read

Citigroup Maintains Neutral on Syneos Health, Lowers Price Target to $55

By Benzinga Newsdesk

October 5, 7:19 AM

Citigroup analyst Patrick Donnelly maintains Syneos Health (NASDAQ:SYNH) with a Neutral and lowers the price target from $70 to $55.

SYNH

56 minute read

Options

Stocks That Hit 52-Week Lows On Thursday

By Benzinga Insights

September 22, 2:17 PM

On Thursday, 1076 companies hit new 52-week lows.

$APE

24 minute read

Options

Stocks That Hit 52-Week Lows On Monday

By Benzinga Insights

September 19, 12:30 PM

On Monday, 429 stocks made new 52-week lows.

ADCT

29 minute read

Options

Stocks That Hit 52-Week Lows On Friday

By Benzinga Insights

September 16, 2:08 PM

During Friday's session, 574 stocks hit new 52-week lows.

ACCO

1 minute read

Baird Maintains Outperform on Syneos Health, Lowers Price Target to $80

By Benzinga Newsdesk

September 16, 8:07 AM

Baird analyst Eric Coldwell maintains Syneos Health (NASDAQ:SYNH) with a Outperform and lowers the price target from $89 to $80.

SYNH

12 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For September 14, 2022

By Benzinga Insights

September 14, 10:07 AM

Upgrades For Iris Energy Ltd (NASDAQ:IREN), Compass Point upgraded the previous rating of Neutral to Buy. The current stock performance of Iris Energy shows a 52-week-high of $17.97 and a 52-week-low of $2.89. Moreover, at the end of the last trading period, the closing price was at $4.26.

AGL